Deal or Case news
NautaDutilh has assisted medical technology company ONWARD Medical raising EUR 20 million in gross proceeds in an accelerated bookbuilding offering.

The offering consisted of a private placement with institutional investors, certain founders, and certain management and board members of the company and a separate public offering via the PrimaryBid platform with retail investors in France.

ONWARD Medical is an inspiring company and it has been a pleasure to work with them and the Skadden team on this complex and innovative transaction.
Paul van der Bijl, Corporate M&A partner

NautaDutilh acted alongside Skadden. Paul van der Bijl and Antonia Netiv led the NautaDutilh team, which further consited of Eline van Marle, Mariëlle van Nimwegen and Daan Hagelstein.

About ONWARD Medical
ONWARD Medical creates innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and movement disorders. ONWARD Medical is listed on Euronext Brussels and Euronext Amsterdam.

Related articles

Cookie notification

This functionality uses third-party cookies. Change your cookie preferences to view this content or view more information.
These cookies ensure that the website works properly. These cookies cannot be disabled.
These cookies can be placed by third parties, such as YouTube or Vimeo.
By deactivating categories, it is possible that related functionalities within the website may no longer work properly. It is always possible to change your preferences at a later time. View more information.